Parallax Volatility Advisers’s Genomic Health, Inc. GHDX Stock Holding History

Parallax Volatility Advisers’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-42	Closed	-$3K	–	4190
2019 Q1	$3K	Buy	+42	New	+$3.11K	﹤0.01%	2626
2018 Q4	–	Sell	-79	Closed	-$6K	–	4410
2018 Q3	$6K	Buy	79 +59	+295%	+$3.45K	﹤0.01%	2304
2018 Q2	$1K	Buy	+20	New	+$794	﹤0.01%	2021
2018 Q1	–	Sell	-2,982	Closed	-$98.9K	–	5057
2017 Q4	$102K	Buy	+2,982	New	+$95.1K	﹤0.01%	2798

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Parallax Volatility Advisers's GHDX Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 42 shares — an estimated $3K sold.

Parallax Volatility Advisers first reported a position in GHDX in Q4 2017 and held it in 4 quarters. The position peaked at $102K in Q4 2017. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Parallax Volatility Advisers reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 42 Genomic Health, Inc. shares in Q2 2019, an estimated $3K.
Parallax Volatility Advisers first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 4 quarters.
Parallax Volatility Advisers's Genomic Health, Inc. position peaked at $102K in Q4 2017.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.